These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18500692)

  • 21. Proteomic profiling of the effect of prostate-specific antigen on prostate cancer cells.
    Bindukumar B; Schwartz S; Aalinkeel R; Mahajan S; Lieberman A; Chadha K
    Prostate; 2008 Oct; 68(14):1531-45. PubMed ID: 18646040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of chelating agents as anti-angiogenic therapy through copper chelation.
    Camphausen K; Sproull M; Tantama S; Venditto V; Sankineni S; Scott T; Brechbiel MW
    Bioorg Med Chem; 2004 Oct; 12(19):5133-40. PubMed ID: 15351396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-silico fragment-based identification of novel angiogenesis inhibitors.
    Dakshanamurthy S; Kim M; Brown ML; Byers SW
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4551-6. PubMed ID: 17591441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-guided design of peptidic ligand for human prostate specific antigen.
    Hassan MI; Kumar V; Somvanshi RK; Dey S; Singh TP; Yadav S
    J Pept Sci; 2007 Dec; 13(12):849-55. PubMed ID: 17890654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish.
    Tran TC; Sneed B; Haider J; Blavo D; White A; Aiyejorun T; Baranowski TC; Rubinstein AL; Doan TN; Dingledine R; Sandberg EM
    Cancer Res; 2007 Dec; 67(23):11386-92. PubMed ID: 18056466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
    Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
    Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of prostate-specific antigen expression by the junctional adhesion molecule A.
    Wang Q; Zheng JY; Kreth J; Yan X; Kamata M; Campbell RA; Xie Y; Chiu R; Berenson JR; Shi W; Chen IS; Pang S
    Urology; 2009 May; 73(5):1119-25. PubMed ID: 18602143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteolytic activity of prostate-specific antigen (PSA) towards protein substrates and effect of peptides stimulating PSA activity.
    Mattsson JM; Ravela S; Hekim C; Jonsson M; Malm J; Närvänen A; Stenman UH; Koistinen H
    PLoS One; 2014; 9(9):e107819. PubMed ID: 25237904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure and anti-proliferation function of 5,5-diphenyl-2-thiohydantoin (DPTH) derivatives in vascular endothelial cells.
    Cheng CK; Wu J; Liu Y; Lee TS; Kang SJ; Sheu MT; Lee WS
    Vascul Pharmacol; 2008; 48(2-3):138-42. PubMed ID: 18295547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural model of human PSA: a target for prostate cancer therapy.
    Hassan MI; Kumar V; Singh TP; Yadav S
    Chem Biol Drug Des; 2007 Sep; 70(3):261-7. PubMed ID: 17718721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategy for sensitive and specific detection of molecular forms of PSA based on 2DE and kinetic analysis: a step towards diagnosis of prostate cancer.
    Kumar V; Hassan MI; Singh AK; Dey S; Singh TP; Yadav S
    Clin Chim Acta; 2009 May; 403(1-2):17-22. PubMed ID: 19118539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Substrates of the prostate-specific serine protease prostase/KLK4 defined by positional-scanning peptide libraries.
    Matsumura M; Bhatt AS; Andress D; Clegg N; Takayama TK; Craik CS; Nelson PS
    Prostate; 2005 Jan; 62(1):1-13. PubMed ID: 15389820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crystal structure of a ternary complex between human prostate-specific antigen, its substrate acyl intermediate and an activating antibody.
    Ménez R; Michel S; Muller BH; Bossus M; Ducancel F; Jolivet-Reynaud C; Stura EA
    J Mol Biol; 2008 Feb; 376(4):1021-33. PubMed ID: 18187150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased frequency and responsiveness of PSA-specific T cells after allogeneic hematopoetic stem-cell transplantation.
    Uhlin M; Okas M; Karlsson H; Gertow J; Henningsohn L; Ringdén O; Kärre K; Levitsky V; Mattsson J
    Transplantation; 2009 Feb; 87(4):467-72. PubMed ID: 19307781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Agents used for chemoprevention of prostate cancer may influence PSA secretion independently of cell growth in the LNCaP model of human prostate cancer progression.
    Peternac D; Klima I; Cecchini MG; Schwaninger R; Studer UE; Thalmann GN
    Prostate; 2008 Sep; 68(12):1307-18. PubMed ID: 18512728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CpG oligonucleotide as an adjuvant for the treatment of prostate cancer.
    Lubaroff DM; Karan D
    Adv Drug Deliv Rev; 2009 Mar; 61(3):268-74. PubMed ID: 19166887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Undetectable level of prostate specific antigen (PSA) nadir predicts PSA biochemical failure in local prostate cancer with delayed-combined androgen blockade.
    Soga N; Arima K; Sugimura Y
    Jpn J Clin Oncol; 2008 Sep; 38(9):617-22. PubMed ID: 18697759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A modified epitope identified for generation and monitoring of PSA-specific T cells in patients on early phases of PSA-based immunotherapeutic protocols.
    Lundberg K; Roos AK; Pavlenko M; Leder C; Wehrum D; Guevara-Patiño J; Andersen RS; Pisa P
    Vaccine; 2009 Mar; 27(10):1557-65. PubMed ID: 19171173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor.
    Zhang Y; Ma Y; Lu HP; Gao JH; Liang CS; Liu CZ; Zou JT; Wang HQ
    Chin Med J (Engl); 2008 Nov; 121(22):2284-9. PubMed ID: 19080333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.